Open AccessEstimation of the level of endothelial factor of vascular growth and monocytic chemoattractant in children cerebral palsy
Author(s) -
Zulfiya M. Nurzhanova,
A.A. Shilova Shilova,
Olga Bashkina,
М. А. Самотруева
Publication year - 2021
Publication title -
čelovek i ego zdorovʹe
Language(s) - English
Resource type - Journals
eISSN - 1998-5754
pISSN - 1998-5746
DOI - 10.21626/vestnik/2021-3/04
Subject(s) - cerebral palsy , medicine , vascular endothelial growth factor , palsy , pediatrics , pathology , physical therapy , vegf receptors , alternative medicine
Objective. The aim of this article is to assess the role of vascular endothelial growth factor and monocytic chemoattractant in the development of cerebral palsy in children. Materials and methods. Examination of 77 children with different clinical forms of infantile cerebral palsy in the age group from 1 to 16 years was carried out. The content of monocyte chemoattractant (MCP) and vascular growth factor (VEGF) was determined in different forms of cerebral palsy. The obtained data were processed statistically. Results. The analysis of the obtained data revealed a significant increase in the indicators of monocytic chemoattractant and vascular growth factor in children with infantile cerebral palsy compared with healthy children. There were no significant differences between the indicators of MCP and VEGF in children with cerebral palsy and comorbid pathology and children with cerebral palsy without concomitant pathology. Conclusion. The authors of the presented analysis conclude that the determination of monocytic chemoattractant and vascular growth factor has a high diagnostic value for identifying a predisposition to the development of cerebral palsy. Timely detection of an increase in the level of these factors provides a broader prospective for early diagnosis of the disease and for the early implementation of rehabilitation measures accordingly.